glp 1 and liver Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Semaglutide improves metabolic liver disease

evaluate the translational evidence supporting GLP-1RAs as candidate disease-modifying therapies for neurodegenerative diseases in this installment to the JCIs Review

Your Skin: What you Need to Know GLP-1 receptor agonists Ozempic, Wegovy, Mounjaro have changed the game for weight loss and diabetes management

CAMP HILL, Pa

Intention-to-treat analyses resulted in an HR of 1.36 (95% CI 0.51, 3.61)

Heart palpitations can occur during GLP-1 therapy, but understanding the mechanisms and proper monitoring helps minimize risk

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.